Demanda Demandas por Fórmula Infantil y Enterocolitis Necrotizante (NEC)

A Missouri state court jury awarded $495 million — including $490 million in punitive damages — to the family of a premature infant who developed NEC and died after being fed Enfamil Premature formula in the NICU. The verdict reflected the jury's finding that Mead Johnson acted with reckless disregard for the safety of premature infants and failed to adequately warn of the NEC risk. The verdict was one of the first major jury verdicts in NEC formula litigation and sent a powerful message to the industry. Post-trial proceedings and appellate review followed.

An Illinois state court jury in Madison County awarded $60 million to the family of a premature infant who developed NEC and died after being fed Enfamil Premature formula at a St. Louis-area NICU. The family alleged that Mead Johnson failed to warn of the scientific evidence linking cow's milk-based formula to elevated NEC risk in premature infants. The verdict included compensatory damages for the family's loss of their child and punitive damages reflecting the jury's assessment of Mead Johnson's conduct.

A bellwether trial in MDL No. 3026 in the United States District Court for the Northern District of Illinois resulted in a $65 million verdict against Abbott Laboratories for the wrongful death of a premature infant who developed NEC and died after being fed Similac Special Care formula. The verdict, one of the first bellwether results in the federal MDL, significantly influenced settlement negotiations for the thousands of cases remaining in the MDL.

A Texas state court jury in Harris County (Houston) awarded $18.5 million to the family of a 28-week premature infant who died from Stage III NEC after being fed Enfamil Premature formula in a Houston-area NICU. The verdict included $12 million in compensatory damages and $6.5 million in punitive damages. The family was represented by a Texas-based product liability firm specializing in mass tort litigation.

A Cook County, Illinois state court jury returned a verdict of $8.95 million against Abbott Laboratories for a premature infant who survived Stage III NEC but suffers from Short Bowel Syndrome and requires long-term parenteral nutrition. The case highlighted the devastating long-term medical costs and quality of life consequences for NEC survivors with permanent bowel damage, including projected lifetime TPN and central line management costs exceeding $2 million.

A bellwether case in MDL 3026 settled for $4.5 million before jury selection. The plaintiff was a premature infant born at 29 weeks who developed NEC at 14 days of age after receiving Enfamil Premature formula in a Chicago-area NICU. The infant survived but developed significant neurodevelopmental disabilities including hypoxic-ischemic brain injury, cerebral palsy, and developmental delays attributed to the systemic sepsis that accompanied NEC. The settlement included compensation for lifetime medical management and special education costs.

A California state court case in Orange County settled for $3.2 million on behalf of a 30-week premature infant who developed NEC after receiving Similac Special Care formula in a Southern California NICU. The infant survived but required two bowel resection surgeries and continues to require supplemental enteral feeding at age four. California's minor tolling rule allowed the family to file the claim despite the NEC having occurred three years prior to filing, well within the window protected by the child's tolled SOL.

An Alabama case resolved for $1.5 million on behalf of the estate of a 26-week premature infant who died from NEC-related septic shock after being fed Enfamil Premature formula at a Birmingham-area NICU. Alabama's contributory negligence doctrine and shorter SOL present unique challenges, but the family's wrongful death claim was filed within two years of the infant's death and proceeded without comparative fault issues. The settlement was reached through mediation with Mead Johnson's national litigation counsel.